Stigma in patients with pigmentary disorders: results of I'Spot study

T. Passeron, L. Wei, A. Morita, C.L. Goh, A. Alexis, B. Dreno, H.Y. Kang, F. Ly, S. Puig, S. Schalka, J. Ocampo Candiani, A.L. Demessant, C. Le Floc’h, D. Kerob, J. Krutmann, H.W. Lim, C. Taieb, K. Ezzedine

  • 10min
  • Oct. 2023
  • Supported by
  • La Roche-Posay
EADV Image

INTRODUCTION AND OBJECTIVES


Pigmentary disorders are a group of skin diseases characterized by changes in skin tone. These diseases can occur at any age, affecting men, women and children of all ethnic backgrounds. They can have a significant impact on the perception of physical health, aesthetic appearance towards patients and deeply affect quality of life. To date, no study have specifically addressed the stigma experienced by individuals with pigmentary disorders. The PUSH-D, a skin specific patient reported outcome assessing stigma, was recently published. It is composed of 17 items, easily understandable regardless of the socio-cultural level of the respondents and has been translated and validated in more than 20 languages (http://www.push-d.org). The higher the Push-D score, the greater the stigma.